Disease: Bowel syndrome segment

NMTR

9 Meters Biopharma, Inc. - Common Stock

-3.95% up -3.98% 0.03

+ Biopharma, Medicine, Disease: Bowel syndrome, Disease: Celiac

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.